SuperGen, Inc. To Present At Wedbush Morgan Small Cap Conference

DUBLIN, Calif., Feb. 24 /PRNewswire-FirstCall/ -- SuperGen, Inc. today announced that Timothy L. Enns, Senior Vice President, Corporate Communications and Business Development, is scheduled to present at the Wedbush Morgan Small Cap Conference, being held at the Le Parker Meridien Hotel in New York City, on Wednesday, March 1, 2006 at 10:45 a.m. ET. Mr. Enns will provide a brief corporate overview and discuss the Company's recent progress.

A live webcast of Mr. Enns' presentation will be available on the Investor Relations section of the Company's website at http://www.supergen.com. The webcast will be archived for 90 days.

About SuperGen

Based in Dublin, California, SuperGen is a pharmaceutical company dedicated to the acquisition, rapid development and commercialization of therapies for solid tumors, hematological malignancies and blood disorders. SuperGen's product portfolio includes: Nipent(R) (pentostatin for injection); Mitomycin (generic brand of Mutamycin(R)); and SurfaceSafe(R) cleaner.

For more information about SuperGen, please visit http://www.supergen.com. Contacts: Timothy L. Enns Sharon Weinstein SuperGen, Inc. Noonan Russo Tel: (925) 560-0100 x111 Tel: (212) 845-4271 E-mail: tenns@supergen.com E-mail: sharon.weinstein@eurorscg.com

SuperGen, Inc.

CONTACT: Timothy L. Enns of SuperGen, Inc., +1-925-560-0100 x111,tenns@supergen.com; or Sharon Weinstein of Noonan Russo, +1-212-845-4271,sharon.weinstein@eurorscg.com

Back to news